1180 related articles for article (PubMed ID: 18942885)
1. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
[TBL] [Abstract][Full Text] [Related]
2. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.
Ledwaba L; Tavel JA; Khabo P; Maja P; Qin J; Sangweni P; Liu X; Follmann D; Metcalf JA; Orsega S; Baseler B; Neaton JD; Lane HC;
PLoS One; 2012; 7(3):e24243. PubMed ID: 22448211
[TBL] [Abstract][Full Text] [Related]
3. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
Baker JV; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon DE; Paton NI; Neaton JD;
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):36-43. PubMed ID: 20930640
[TBL] [Abstract][Full Text] [Related]
4. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Nordell AD; McKenna M; Borges ÁH; Duprez D; Neuhaus J; Neaton JD; ;
J Am Heart Assoc; 2014 May; 3(3):e000844. PubMed ID: 24870935
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection.
Gupta M; Miller CJ; Baker JV; Lazar J; Bogner JR; Calmy A; Soliman EZ; Neaton JD;
Am J Cardiol; 2013 Mar; 111(5):760-4. PubMed ID: 23276469
[TBL] [Abstract][Full Text] [Related]
6. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
[TBL] [Abstract][Full Text] [Related]
7. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
Rodger AJ; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis A; Goetz MB; Phillips AN;
J Infect Dis; 2009 Sep; 200(6):973-83. PubMed ID: 19678756
[TBL] [Abstract][Full Text] [Related]
8. The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.
Hamlyn E; Stöhr W; Cooper DA; Fisher M; Tambussi G; Schechter M; Miro JM; Vanobberghen F; Babiker A; Weber J; Mcclure M; Porter K; Fidler S;
AIDS; 2015 Jul; 29(11):1355-61. PubMed ID: 25870986
[TBL] [Abstract][Full Text] [Related]
9. Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
So-Armah KA; Tate JP; Chang CH; Butt AA; Gerschenson M; Gibert CL; Leaf D; Rimland D; Rodriguez-Barradas MC; Budoff MJ; Samet JH; Kuller LH; Deeks SG; Crothers K; Tracy RP; Crane HM; Sajadi MM; Tindle HA; Justice AC; Freiberg MS;
J Acquir Immune Defic Syndr; 2016 Jun; 72(2):206-213. PubMed ID: 27824677
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
[TBL] [Abstract][Full Text] [Related]
11. Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy.
Achhra AC; Phillips A; Emery S; MacArthur RD; Furrer H; De Wit S; Losso M; Law MG;
HIV Med; 2015 Aug; 16(7):449-54. PubMed ID: 25959989
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
Bjerk SM; Baker JV; Emery S; Neuhaus J; Angus B; Gordin FM; Pett SL; Stephan C; Kunisaki KM;
PLoS One; 2013; 8(2):e56249. PubMed ID: 23457535
[TBL] [Abstract][Full Text] [Related]
13. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
[TBL] [Abstract][Full Text] [Related]
15. Platelet count kinetics following interruption of antiretroviral treatment.
Zetterberg E; Neuhaus J; Baker JV; Somboonwit C; Llibre JM; Palfreeman A; Chini M; Lundgren JD;
AIDS; 2013 Jan; 27(1):59-68. PubMed ID: 23018440
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
Palella FJ; Gange SJ; Benning L; Jacobson L; Kaplan RC; Landay AL; Tracy RP; Elion R
AIDS; 2010 Jul; 24(11):1657-65. PubMed ID: 20588104
[TBL] [Abstract][Full Text] [Related]
17. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.
Neuhaus J; Jacobs DR; Baker JV; Calmy A; Duprez D; La Rosa A; Kuller LH; Pett SL; Ristola M; Ross MJ; Shlipak MG; Tracy R; Neaton JD
J Infect Dis; 2010 Jun; 201(12):1788-95. PubMed ID: 20446848
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.
Duprez DA; Neuhaus J; Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon D; Paton NI; Prineas RJ; Neaton JD;
PLoS One; 2012; 7(9):e44454. PubMed ID: 22970224
[TBL] [Abstract][Full Text] [Related]
19. Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy.
Silva EF; Charreau I; Gourmel B; Mourah S; Kalidi I; Guillon B; De Castro N; Caron F; Braun J; Molina JM;
J Infect Dis; 2013 Sep; 208(6):892-7. PubMed ID: 23801606
[TBL] [Abstract][Full Text] [Related]
20. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.
Borges ÁH; Silverberg MJ; Wentworth D; Grulich AE; Fätkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD; ; ;
AIDS; 2013 Jun; 27(9):1433-41. PubMed ID: 23945504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
